Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Rhodes Pharmaceuticals L.P.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Rhodes Pharmaceuticals L.P. with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Rhodes Pharmaceuticals L.P.
Package NDC
42858-161-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.